Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Selinexor in Richter's Transformation
NCT02138786Phase 2Terminated
- Sponsor
- Karyopharm Therapeutics Inc.
- Start
- Nov 2014
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 5
01
Overview
Phase 2, open-label, single-arm trial of selinexor in Richter's transformation (RT), sponsored by Karyopharm Therapeutics Inc. Primary endpoints: Overall Response Rate, Complete Response and 4 more. Started Nov 2014; status: terminated.
02
Drugs
selinexor
03
Conditions
Richter's transformation (RT)
Beyond the preview
Go deeper on NCT02138786.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02138786.